{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:21:31Z","timestamp":1787026891242,"version":"build-2736575974"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>The protein p53 is the main human tumor suppressor. Since its discovery, extensive research has been conducted, which led to the general assumption that the purview of p53 is also essential for additional functions, apart from the prevention of carcinogenesis. In response to cellular stress and DNA damages, p53 constitutes the key point for the induction of various regulatory processes, determining whether the cell induces cell cycle arrest and DNA repair mechanisms or otherwise cell death. As an implication, aberrations from its normal functioning can lead to pathogeneses. To this day, neurodegenerative diseases are considered difficult to treat, which arises from the fact that in general the underlying pathological mechanisms are not well understood. Current research on brain and retina-related neurodegenerative disorders suggests that p53 plays an essential role in the progression of these conditions as well. In this review, we therefore compare the role and similarities of the tumor suppressor protein p53 in the pathogenesis of Alzheimer\u2019s (AD) and Parkinson\u2019s disease (PD), two of the most prevalent neurological diseases, to the age-related macular degeneration (AMD) which is among the most common forms of retinal degeneration.<\/jats:p>","DOI":"10.3389\/fnins.2022.1029473","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:41:29Z","timestamp":1671590489000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["The function of p53 and its role in Alzheimer\u2019s and Parkinson\u2019s disease compared to age-related macular degeneration"],"prefix":"10.3389","volume":"16","author":[{"given":"Peter","family":"Wolfrum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Fietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Schnichels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00732-0","article-title":"The pleiotropic role of p53 in functional\/dysfunctional neurons: Focus on pathogenesis and diagnosis of Alzheimer\u2019s disease.","volume":"12","author":"Abate","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/BTT.S252581","article-title":"Gene, cell and antibody-based therapies for the treatment of age-related macular degeneration.","volume":"14","author":"Akyol","year":"2020","journal-title":"Biologics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.exer.2003.10.011","article-title":"Characterization of beta amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration.","volume":"78","author":"Anderson","year":"2004","journal-title":"Exp. Eye Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/fn.2020.96707","article-title":"What causes neurodegenerative disease?","volume":"58","author":"Armstrong","year":"2020","journal-title":"Folia Neuropathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5114\/fn.2019.85929","article-title":"Risk factors for Alzheimer\u2019s disease.","volume":"57","author":"Armstrong","year":"2019","journal-title":"Folia Neuropathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease.","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2741\/S415","article-title":"Parkinson\u2019s disease: A review.","volume":"6","author":"Beitz","year":"2014","journal-title":"Front. Biosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"8350","DOI":"10.1167\/iovs.12-10495","article-title":"Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association.","volume":"53","author":"Bhattacharya","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"ORSF68","DOI":"10.1167\/iovs.13-12757","article-title":"Dry age-related macular degeneration: Mechanisms, therapeutic targets, and imaging.","volume":"54","author":"Bowes Rickman","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/onc.2008.310","article-title":"Lysosomal membrane permeabilization in cell death.","volume":"27","author":"Boya","year":"2008","journal-title":"Oncogene"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.1038\/sj.onc.1204484","article-title":"Tissue specific expression of p53 target genes suggests a key role for KILLER\/DR5 in p53-dependent apoptosis in vivo.","volume":"20","author":"Burns","year":"2001","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy.","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000329999","article-title":"Role of p53 in neurodegenerative diseases.","volume":"9","author":"Chang","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"B15","first-page":"407","article-title":"Neurodegenerative diseases.","volume":"163","author":"Checkoway","year":"2011","journal-title":"IARC Sci. Publ."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-02196-8","article-title":"Increased risk of Parkinson\u2019s disease among patients with age-related macular degeneration.","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Ophthalmol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1038\/sj.onc.1204373","article-title":"The role of tetramerization in p53 function.","volume":"20","author":"Chene","year":"2001","journal-title":"Oncogene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajo.2019.11.001","article-title":"Association of age-related macular degeneration on Alzheimer or Parkinson disease: A retrospective cohort study.","volume":"210","author":"Choi","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.835288","article-title":"Post-translational modifications of the p53 protein and the impact in Alzheimer\u2019s disease: A review of the literature.","volume":"14","author":"Clark","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2006.05.034","article-title":"DRAM, a p53-induced modulator of autophagy, is critical for apoptosis.","volume":"126","author":"Crighton","year":"2006","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.bbrc.2005.03.149","article-title":"P53 in neuronal apoptosis.","volume":"331","author":"Culmsee","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0022-510x(97)00131-7","article-title":"Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer\u2019s disease.","volume":"152","author":"de la Monte","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","article-title":"The burden of neurological diseases in Europe: An analysis for the Global Burden of Disease Study 2017.","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.2174\/0929867323666161213101126","article-title":"Alzheimer\u2019s disease: A review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment.","volume":"25","author":"Dos Santos Picanco","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0306-4522(99)00313-9","article-title":"Early postnatal Muller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice.","volume":"95","author":"Dubois-Dauphin","year":"2000","journal-title":"Neuroscience"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ph11020044","article-title":"Old drugs as new treatments for neurodegenerative diseases.","volume":"11","author":"Duraes","year":"2018","journal-title":"Pharmaceuticals"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01012-6","article-title":"P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer\u2019s disease.","volume":"8","author":"Farmer","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neurobiolaging.2014.10.007","article-title":"Abeta induces PUMA activation: A new mechanism for Abeta-mediated neuronal apoptosis.","volume":"36","author":"Feng","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.neurobiolaging.2008.09.018","article-title":"A role for p53 in the beta-amyloid-mediated regulation of the lysosomal system.","volume":"31","author":"Fogarty","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"B30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/opo.12675","article-title":"Risk factors for progression of age-related macular degeneration.","volume":"40","author":"Heesterbeek","year":"2020","journal-title":"Ophthalmic Physiol. Opt."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1107\/S090744490603890X","article-title":"High-resolution structure of the p53 core domain: Implications for binding small-molecule stabilizing compounds.","volume":"62","author":"Ho","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/1096-9861(20000828)424:3<476::aid-cne6>3.0.co;2-0","article-title":"Developmental cell death in dopaminergic neurons of the substantia nigra of mice.","volume":"424","author":"Jackson-Lewis","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","article-title":"Structural biology of the tumor suppressor p53.","volume":"77","author":"Joerger","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in Context.","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/1947601911408893","article-title":"P53 isoforms: An intracellular microprocessor?","volume":"2","author":"Khoury","year":"2011","journal-title":"Genes Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1006\/bbrc.1997.6301","article-title":"Changes of p53 in the brains of patients with Alzheimer\u2019s disease.","volume":"232","author":"Kitamura","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/oxfordjournals.bmb.a072911","article-title":"P53 and human cancers.","volume":"50","author":"Lane","year":"1994","journal-title":"Br. Med. Bull."},{"key":"B38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1023\/a:1001795526628","article-title":"The mouse ERG before and after light damage is independent of p53.","volume":"96","author":"Lansel","year":"1998","journal-title":"Doc. Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: Growing ever more complex.","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bjophthalmol-2019-314422","article-title":"Prevalence and incidence of age-related macular degeneration in Europe: A systematic review and meta-analysis.","volume":"104","author":"Li","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050851","article-title":"Ubiquitination-proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress.","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"B42","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/acschemneuro.8b00356","article-title":"Balancing apoptosis and autophagy for Parkinson\u2019s disease therapy: Targeting BCL-2.","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209328","article-title":"Views of ophthalmologists on the genetics of age-related macular degeneration: Results of a qualitative study.","volume":"13","author":"Loss","year":"2018","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.1093\/nar\/gku501","article-title":"Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters.","volume":"42","author":"Loughery","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12640-017-9723-z","article-title":"Dopaminergic neuron-specific deletion of p53 Gene attenuates methamphetamine neurotoxicity.","volume":"32","author":"Lu","year":"2017","journal-title":"Neurotox. Res."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6600944","article-title":"Association of p53 with neurodegeneration in Parkinson\u2019s disease.","volume":"2022","author":"Luo","year":"2022","journal-title":"Parkinsons Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1046\/j.1471-4159.2002.01144.x","article-title":"A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism.","volume":"83","author":"Mandir","year":"2002","journal-title":"J. Neurochem."},{"key":"B48","first-page":"846","article-title":"Light-induced cell death of retinal photoreceptors in the absence of p53.","volume":"39","author":"Marti","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","article-title":"PARP-1 involvement in neurodegeneration: A focus on Alzheimer\u2019s and Parkinson\u2019s diseases.","volume":"14","author":"Martire","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1167\/iovs.09-3639","article-title":"Relationship between RPE and choriocapillaris in age-related macular degeneration.","volume":"50","author":"McLeod","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030420","article-title":"Role of p53 in the regulation of cellular senescence.","volume":"10","author":"Mijit","year":"2020","journal-title":"Biomolecules"},{"key":"B52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neuro.2005.06.001","article-title":"Photoreceptor cell apoptosis induced by the 2-nitroimidazole radiosensitizer, CI-1010, is mediated by p53-linked activation of caspase-3.","volume":"27","author":"Miller","year":"2006","journal-title":"Neurotoxicology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration.","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1749-6632.2009.05108.x","article-title":"Advances in the treatment of neurodegenerative disorders employing nanotechnology.","volume":"1184","author":"Modi","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"P53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B56","first-page":"1001","article-title":"The MDM2-p53 interaction.","volume":"1","author":"Moll","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrm3823","article-title":"Cellular senescence: From physiology to pathology.","volume":"15","author":"Munoz-Espin","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0047-6374(99)00064-0","article-title":"Cell death of dopamine neurons in aging and Parkinson\u2019s disease.","volume":"111","author":"Naoi","year":"1999","journal-title":"Mech. Ageing Dev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/s0892-0362(02)00213-1","article-title":"Apoptotic molecules and MPTP-induced cell death.","volume":"24","author":"Nicotra","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"key":"B60","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1523\/JNEUROSCI.16-23-07533.1996","article-title":"Amyloid beta peptide of Alzheimer\u2019s disease downregulates Bcl-2 and upregulates bax expression in human neurons.","volume":"16","author":"Paradis","year":"1996","journal-title":"J. Neurosci."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0608-2","article-title":"BCL-2 as therapeutic target for hematological malignancies.","volume":"11","author":"Perini","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/s0092-8674(01)00619-5","article-title":"Why is p53 acetylated?","volume":"107","author":"Prives","year":"2001","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/cancers7010030","article-title":"P53 acetylation: Regulation and consequences.","volume":"7","author":"Reed","year":"2014","journal-title":"Cancers"},{"key":"B64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jmb.2012.10.015","article-title":"The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.","volume":"425","author":"Retzlaff","year":"2013","journal-title":"J. Mol. Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes.","volume":"9","author":"Riley","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"6440","DOI":"10.1002\/anie.200600611","article-title":"P53\u2013a natural cancer killer: Structural insights and therapeutic concepts.","volume":"45","author":"Romer","year":"2006","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.cdd.4402058","article-title":"P53 downstream target genes and tumor suppression: A classical view in evolution.","volume":"14","author":"Rozan","year":"2007","journal-title":"Cell Death Differ."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100880","article-title":"Retina in a dish: Cell cultures, retinal explants and animal models for common diseases of the retina.","volume":"81","author":"Schnichels","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrm1200","article-title":"Nuclear and unclear functions of SUMO.","volume":"4","author":"Seeler","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1568007053005127","article-title":"Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: Therapeutic implications.","volume":"4","author":"Shacka","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s0092-8674(00)80416-x","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/00001756-199907130-00030","article-title":"In situ localization of p53, bcl-2 and bax mRNAs in rat ocular tissue.","volume":"10","author":"Shin","year":"1999","journal-title":"Neuroreport"},{"key":"B73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.colsurfb.2006.11.003","article-title":"The p53 network: p53 and its downstream genes.","volume":"55","author":"Shu","year":"2007","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B74","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/embor.2010.159","article-title":"The history of p53. A perfect example of the drawbacks of scientific paradigms.","volume":"11","author":"Soussi","year":"2010","journal-title":"EMBO Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/jmbi.1996.0560","article-title":"How phosphorylation regulates the activity of p53.","volume":"263","author":"Steegenga","year":"1996","journal-title":"J. Mol. Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function.","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol. Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00005072-199701000-00009","article-title":"Bax protein expression is increased in Alzheimer\u2019s brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology.","volume":"56","author":"Su","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"506","DOI":"10.14336\/AD.2016.1120","article-title":"P53 dysfunction in neurodegenerative diseases - the cause or effect of pathological changes?","volume":"8","author":"Szybinska","year":"2017","journal-title":"Aging Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ebiom.2017.05.017","article-title":"The transcriptional landscape of p53 signalling pathway.","volume":"20","author":"Tanikawa","year":"2017","journal-title":"EBioMedicine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1517\/14728222.2013.733001","article-title":"Targeting the Bcl-2 family for cancer therapy.","volume":"17","author":"Thomas","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"B81","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1523\/JNEUROSCI.20-04-01386.2000","article-title":"Caspase-2 mediates neuronal cell death induced by beta-amyloid.","volume":"20","author":"Troy","year":"2000","journal-title":"J. Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1242\/jcs.115.15.3131","article-title":"Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer\u2019s disease patients.","volume":"115","author":"Uberti","year":"2002","journal-title":"J. Cell Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000113704","article-title":"Conformationally altered p53: A putative peripheral marker for Alzheimer\u2019s disease.","volume":"5","author":"Uberti","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1167\/iovs.11-8909","article-title":"Expression and role of p53 in the retina.","volume":"53","author":"Vuong","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1158\/0008-5472.CAN-15-0563","article-title":"P53: Protection against tumor growth beyond effects on cell cycle and apoptosis.","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.584974","article-title":"Targeting Bcl-2 proteins in acute myeloid leukemia.","volume":"10","author":"Wei","year":"2020","journal-title":"Front. Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10495-008-0285-7","article-title":"Involvement of c-Abl, p53 and the MAP kinase JNK in the cell death program initiated in A2E-laden ARPE-19 cells by exposure to blue light.","volume":"14","author":"Westlund","year":"2009","journal-title":"Apoptosis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1017\/s0317167100013949","article-title":"Early-onset familial Alzheimer\u2019s disease (EOFAD).","volume":"39","author":"Wu","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180992","article-title":"Apoptosis and apoptotic body: Disease message and therapeutic target potentials.","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci. Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1590\/s1807-59322011000500006","article-title":"The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration.","volume":"66","author":"Yildirim","year":"2011","journal-title":"Clinics"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s00018-016-2202-5","article-title":"Regulation of necrotic cell death: p53, PARP1 and cyclophilin D-overlapping pathways of regulated necrosis?","volume":"73","author":"Ying","year":"2016","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.1029473\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:41:36Z","timestamp":1671590496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.1029473\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":91,"alternative-id":["10.3389\/fnins.2022.1029473"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.1029473","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"article-number":"1029473"}}